Abstract -Contributions to the chemistry of 0-lactam antibiotics which have been performed for the past fifteen years are summarized. The work comprises syntheses of 1-oxa nuclear analogues of naturally occurring 0-lactam antibiotics in relation with structure-activity relationships. As the result of these studies several promisin compounds of the 1-oxacephem series were found. Among properties and are currently used clinica ly as the third and the fourth generation p-lactam antibiotics respectively. Unstable 1-oxapenem derivatives 61a, b, c were also synthesized and tested for their biological roperties. It was demonepi-thienamycin B rather than clavulanic acid. Highly strained tricyclic l-oxace hem derivative 86 was also synthesized. Disappointingly this unique 0-factam compound showed only weak activity against gram-positive bacteria. In addition to this 1-oxacephem derivatives, a ractically useful synthetic method for 3'-nor-cephalosporin nucleus was establisted and applied to the production of an oral 0-lactam antibiotic, ceftibuten 11, which was recently discovered in Shionogi Research Laboratories. f these, latamoxe f I8 and flomoxef 33 proved to have excellent biological strated that these compounds were the strong cepha P osporinase inhibitors like
INTRODUCTION
As is well known, the so-called semisynthetic penicillins and cephalosporins, which are chemically derived from the corres onding naturally occurring p-lactams such as penicillin G 1 and their dramatic efficacy and little adverse effect. The situation has not been altered even at the present time, rather the excitement of and interest in the 0-lactam antibiotics have been raised to a peak by the recent discovery of the so-called non-classical 0-lactam antibiotics such as clavulanic acid 3, thienamycin 4 and monobactam (sulfazecin) 5, whose biological properties have been found conspicuously unique. cephalosporin C 2, have p P ayed a principal role in treating infectious diseases for a long time owing to It has been remarkabl recognized that chemical rnodiications of penicillins or cephalosporins to obtain 0-lactams exhibiting better biological properties had been carried out mostly a t the side chain parts of the mother compounds until early in the 1970's, and, to our knowledge, o n l y a few instances at the nuclear parts a t the time when we started p-lactam research in 1974. We suspected that the side chain modifications had been worked o u t by t h e precedent other research groups and that we were too late to obtain a new and useful side chain in our hand. We, therefore, decided to explore the possibility of nuclear modification. T h i s s t r a t e g y seemed to be appropriate and even effective from the view point that remarkable progress had been made in the action mechanism and in the structure-activity relationships of 0-lactam antibiotics. The plans included: (1) synthesis of the 3'-nor cephalosporin nucleus 6, (2) synthesis of the 1-oxa-1-dethia cephalosporin nucleus 7, and (3) synthesis of the penem nucleus 8. The last plan was later cancelled, because there was a rumor that Professor R. B. Woodward (deceased, July 8, 1979 ) accomplished synthesis of a penem compound which was found very labile.
3'-NORCEPHALOSPORINS, CEFTIBUTEN A N D ITS SYNTHESIS
Soon after we began the synthesis, we noticed that two orally effective P-lactams of the second generation had been developed, the one being cefaclor (CCL) 9 discovered in Eli Lilly Laboratories and the other being cefroxadine (CXD) 10 in Woodward Institute in Basle. Both compounds belong to the 3'-nor type cephalosporin as illustrated and good synthetic methods were also reported to be developed i n each laboratories. Our efforts had been centered also upon developement of our own efficient, practical synthetic method which was achieved by the end of 1974 (ref. 1) . The key steps in the synthesis is functionalization at the terminal methyl group in 13 to obtain 14 which on acid hydrolysis can be converted into the 3'-norcephalosporin 15 very smoothly. This functionalization was effected by treating the thiazolidinoazetidinone 13 successively with MsCl/Et3N/THF, morpholine and bromine at a low temperature. In another project a practically useful method was developed for ester deprotection
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which comprises the use of AlCl3 in the presence of anisole a t a low
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t e m p e r a t u r e (ref.
2 ) a n d t h e method was successfully applied to the present synthesis. CHART 3 It is worthy to add t h a t very recently a new oral cephalosporin 11 named ceftibuten (ref.
3 ) w a s discovered in our laboratories. Unusually high absorbability in oral administration is characteristic of this cephalosporin and this compound is now under clinical evaluation as a third generation oral cephalosporin. T h e s y n t h e t i c method just shown in this chart is now nicely applied to the production of ceftibuten on an industrial scale.
1-OXACEPHEMS (I), LATAMOXEF ( M O X A L A C T A M )
In parallel with the project described above, considerable efforts had also been made to synthesize l-oxa-l-dethia-3-cephem-4-carboxylic acid (abbreviated as 1-oxacephem in the present paper). However, we felt completely frustrated when we noticed the successful syntheses reported independently by S. Wolfe In particular the work of the latter group deserves admiration, since they showed for the first time that 1-oxacephalothin l6, though in a racemic form, exhibited antibacterial activity as high as its 1-thia congener, cephalothin, and that 1-sulfur atom in cephalosporins was not essential for exhibiting the activity.
Despite this discouragement we still continued the study ex ecting t h a t there would be some possibility of finding a promising compound in this new class ofp-lactam antibiotics. In the meantime we succeeded also in synthesizing 1-oxa analogs of desacetyl cephalosporin derivatives and subsequently 1-oxacephalothin 16 in a n optically active form. We were then encouraged a great deal by the finding that our sample of 16 showed activity several times higher than that reported by the Merck group and were further excited by the fact that 1-oxacephem derivative 17 was found to be eight to sixteen times as active as the corresponding 1-thia congener. A number of 1-oxacephems were then pre ared and subjected to a primary assay program. As a result we succeeded in discovering latamoxeP(moxa1actam) (ref. 6) 18, the biological activities of which were thoroughly investigated by our biologists showing its extraordinary high and broad activity against gram-negative b a c t e r i a i n c l u respectively. This illustration clearly shows that latamoxef is uppermost as a chemotherapeutic agent at least for treating infectious diseases caused by pathogenic gram-negative bacteria.
Although we thus attained the initial purpose to get a promising compound in hand, there seemed little prospect of commercial success, because the structural complexity of latamoxef made it almost impossible to establish an industrially feasible synthetic route. Indeed, it was clear that our first synthetic method was never practical and we had to challen e this serious problem which was standwell sophisticated and industrially feasible synthetic route. P chloride giving 29 in good yield. A number of useful synthetic methods were developed for converting this chloride 29, via the ally1 alcohol 23 and 3-exomethylene 1-oxacepham 24, into either latamoxef (LMOX) or flomoxef (FMOX) and the latter compound will be a topic in the following section.
The synthetic method was further developed by the people of the process research and development section (Production Department) for large scale production. The procedures thus developed are now carried out at our Kanegasaki plant where latamoxef and flomoxef were produced on multi ton scales ( hoto-picture of Kanegasaki plant). This success in large scale production made it possible to supply ratamoxef in abundance, meanin that latamoxef was now qualified for a therapeutic agent. In fact, it has been broadly used clinicafy for treating infectious diseases. It should be pointed out that, latamoxef is quite unique in its history in that it is the first and the only p-lactam antibiotic with an unnatural nuclear structure.
OXACEPHEMS (2), FLOMOXEF A N D THE RELATED p-LACTAM ANTIBIOTICS
In the previous section, I have mentioned that latamoxef has been broadly used clinically, as one of the representative third generation p-lactam antibiotics. However, des ite its excellent activity drawbac f a of wea activity against Staphylococcus uureus. Therefore, our next target was to find a new oxacephem antibiotic exhibiting stron activity not only against ram negative but also gramgram-positive and gram-negative bacteria.
against ram-ne ative bacteria, latamoxef, as other third generation 0-P actam antibiotics, has a positive bacteria, in other words, activity o f the new antibiotic should i e well balanced against both
In the beginning we adopted a strategy which comprised, (1) search for an excellent cephalosporin 7p-side chain 31 in the literature, and (2) introduction of this side chain into the 1-oxacephamycin nucleus 32 (7a-methoxy-1-oxacephem). This articular nucleus was selected as the best from the adverse reactions. Literature inspection suggested that certain alkylthio-or substituted alkylthioacetamido side chains, RISCH2CONH; might be promising. For example, trifluoromethylthioacetamido or cyanomethylthioacetamido groups were used respectively for cefazaflur (ref. 8) or cefmethazole (ref. 9) which were reported to exhibit enhanced gram-positive activity. These groups were now introduced into the nucleus 32 (Rz = CH3) to obtain 33a, 33b and 33c. Among these, 33b bearing the trifluoromethylthio-acetamido side chain was found to be most active against grampositive and gram-negative bacteria and exhibit even a 4-63 fold enhanced activity as compared with that of 1-thia congener. Unfortunately, however, preparation of this side chain, that is, the corresponding trifluorothio-acetic acid 31 (R1 = CF3) seemed to be laborious. Thus, according to the literature (ref. 8) , this acid could only be prepared by replacement of methyl iodoacetate with silver trifluoromethylsulfide followed by alkali hydrolysis. Moreover, preparation of the latter reagent, AgSCF3, required heating silver fluoride and carbon disulfide in an autoclave, the procedure being never industrial, as you can see from the equation in Chart 7. We therefore planned to substitute difluoromethyl for trifluoromethyl, since difluoromethylthioacetic acid 31 (R1 = CHF2) could be more easily obtained by reaction of thioglycolic acid ester with difluorocarbene, which was generated in situ by treatment of cheap chlorodifluoromethane (Freon 22) with base, and by subsequent alkaline hydrolysis as shown in Chart 7. In accord with our expectation, the difluoromethylthioacetamido-1-oxacephem 33d was found to exhibit antibacterial activity comparable with that of trifluoro congener 33b. Next, we prepared 33e, 33f, and 33g in which cyanoethyl, carbamoyl methyl or hydroxyethyl was substituted for N1-methyl in the tetrazole ring in 33d. The DurDose of this modification was to avoid a viewpoints of activity against various kinds of 6 acteria, stability to p-lactamases, pharmacology, and
RlSCHKOOH -t I disulhraA-like adverse reaction which was assumed to be ascribed to the N1-methyl tetrazolylthio moiety. The 1-oxacephem nucleus bearing the N1-substituted tetrazolylthio group at C37 was first prepared and coupled with difluoromethylthioacetic acid in the usual way. The antibacterial activity of the three oxacephems, 33e, 33f, and 33g was very high and compared well with each other and also with the original N1-methyl analog 33d. S nthesis of the acid 39 corresponding to the side chain 35 was thus carried out (ref. 11). Treatment ofmethyl chloroethylthioacetate 37 with DBU followed by chlorination gave dichlorothioacetate 38. When this ester was subjected to dehydrochlorination by heatin with lithium chloride followed by alkaline hydrolysis, we could obtain cis chlorovinylthioacetic acif39 as a major product. In contrast, the synthesis of the fluoro analog 43 was not easy. The starting methyl fluoroethylthioacetate 40 was first chlorinated and the resulting dichloroderivative was oxidized with m-chloroperbenzoic acid to obtain the dichloro-S-oxide 41. Pummerer reaction of this S-oxide was successful only by the use of triflic acid anhydride and 4-methyl-2,6-di-tert-butyl pyridine giving, to our surprise, exclusively the desired cis fluorovinylthio derivative 42, which was then dechlorinated with zinc and acetic acid, and * the methods given in Chart 9. The syntheses involved no particular reaction to be commented, but I would like only to point out that, i n the conversion of 45 into 46, thioglycolate, and elimination of hydrogen chloride took place at once.
cis-chlorovinylthioacetamido-oxacephems
were prepared and their antibacterial acHiNCO tivity was compared. Among these, the carbamoyl derivative was found to exhibit the highest and the most balanced activity.
CHART 9 49
Therefore, two carbamoyl substituted fluoro counterparts 50a and 50b were prepared and tested for their antibacterial activity and also for pharmacological behaviour. Both exhibited satisfactory antibacterial activity and spectra. It was further shown that the carbamoyl substitution actually improved the pharmacology significantly as can be seen from Table 2 . The AUC values and the half-lives for 50a and Sob are larger than those for the non-substituted congeners 44e and 44d. The one containing the hydroxyethyltetrazolethio substituent a t C3' was selected for development with the code number of 2355s. Further investigation of its antibacterial profile using clinical bacterial isolates showed that the antibacterial atterns of 2355-S and flomoxef are almost superimposable. It was also shown that 2355s had t i e distinct advantage of su erior pharmacological roperties, that is, its AUC value and half-life were, respectively, one and a !alf times and twice as farge as those of flomoxef when administered through intravenous drip infusion to normal volunteers. CHART 10 there is a iossibility 'for 54'to undergo intramolecular nucleophilic attack by participation of the 6P-acid amido group and, thus, this penem is most labile and only weakly active. The P-lactam ring in 55 is most exposed to nucleophilic attack due to the absence of a Cg-substituent and t h u s i t s stability is estimated as intermedi-
ary. For the penem 52 (R = H)
the situation may be most favourable, because i t may be moderately stable owing the the existence -of the neighbouring hydroxyethyl substituent.
On the basis of the above consideration we undertook the synthesis of the 1-oxapenem 53 bearing hydroxyethyl at 6a. It should be noted that studies on 1-oxapems are very few, although there have been abundant reports on the 1-oxapenams in relation to clavulanic acid. Moreover, no report has been published on the synthesis of 1-oxapenem bearing the hydroxyethyl substituent. This situation may be reasonable if one presumes that 1-oxapenem is extremely unstable.
The syntheses were carried out principally according to the method reported by T. Kametani et al. (ref. 15) . The reaction sequence is given in Chart 11. Commercially available, optically active azetidinone 57 was converted into 58 which was acylated with various acid chlorides to obtain P-keto- 1 ) Enzymes were crude extracts 2) C:Cephalosporinare; P: Peniciliinase 3) Minimum effective concentration was determined by spot test uaing Nitrocelin esters 69a, b, c. These azetidino-ketoesters after desilylation were chlorinated to 60a, b, c which underwent intramolecular cyclization by treatment with triethylamine and the subsequent ester deprotection by catalytic hydrogenation to obtain the desired l-oxacephems 61a, b, c. Their half-lives at pH 7.0 and 37°C were determined to be 43,24, and 200 min, respectively. While the first two compounds were unstable as anticipated, the last compound was surprisingly stable as judged from its half-life value of 200 min. In accord with their stability the former two oxapenems 61a and b were virtually inactive, whereas the 2-isopropyloxapenem 61c exhibited activity which was weak but a little bit better than clavulanic acid. It was quite interesting, however, that all these three oxapenems were found to have very strong p-lactamase inhibitory activity as listed n Table 3 . This l-oxapenem inucleus is equipped with both of the l-oxygen atom of clavulanic acid and the 2,3-double bond of carbapenem. These structural elements are closely associated with the biolo ical activity of the two classes of p-lactam compound. Now what would be the effect of incorporating%oth of the structural elements within the same molecule? As can be seen from this table, all the cephalosporinases tested were sensitive to l-oxapenems. Their inhibitory spectrum is similar to that of epithienamycin B and not of clavulanic acid. It should be noted that this fact might be interesting from the view-point of the mode of action.
p-LACTAM ANTIBIOTICS LACKING ACYLAMIDO SIDE CHAIN (2) 1 -0 X A C E P H E M S
It is a matter of common knowledge that there are two elemental factors controlling the activity of p-lactam antibiotics, that is, the chemical reactivity of the P-lactam ring to acylate the peptidoglycan transpeptidase and the shape of the p-lactam molecule which determines the binding-affinity to the enzyme. As discussed previously, the shape of the molecule is also related to the reactivity of the p-lactam ring, when the molecule possesses ring strain. In a quantitative sense, as the reactivity is increased, the antibacterial activity becomes stronger at least within certain limits. We centered our attention firstly on increasing the chemical reactivity electronically and, secondly, on making up the molecule in a bent form. 
CHART 12
As I referred to already, in the classical P-lactam antibiotics there is a limitation to increasing the reactivity electronically by introducing a n electron-withdrawing substituent a t an appropriate position, because such a modification results in the decomposition of the -1actam ring by intra- Antibacterial assay showed that these compounds were actually active, as predicted, but the activity was, in a quantitative sense, quite disappointing. The nitrile 71c, which was strongest among them, showed MIC values of 12.5-25 pg/ml against various Staphylococcus aureus strains and 50-100 pg/ml against E . coli, Klebsiella and Enterobacter species.
P-LACTAM ANTIBIOTICS LACKING ACYLAMIDO SIDE CHAIN (3) BRIDGED 1-OXACEPHEMS
We finally challenged the synthesis of a bent 1-oxacephem which might have a good binding affinity to the target enzyme and at the same time a constraint imposed in such a molecule will increase the 0-lactam reactivity as I referred to in the foregoing discussions. Now, what is the way to construct such a bent molecule which still contains the 1-oxacephem ring? In Chart 15 are given perspective views of representative 0-lactam antibiotics. While the molecules of cephalosporin 72a and l-oxacephalosporin 73a are rather flat, those of penicillin 1 and thienamycin 74a are greatly folded. As discussed previously, as the folding is greater, the activity becomes stronger. There was a formalism for determining the degree of the folding, that is, for defining the critical departure from coplanarity to be formed by the amide resonance. A trigonal yramid is ima ined in A, the corners of whose base are C3, C5, and C7, while N-4 is at its apex; the aftitude h from t f e apex to the base, will be larger as the departure from coplanarity increases. The h values have been determined for various 0-lactam antibiotics: those were 0.20,0.23,0.40 and 0.49 A for cephalosporin 72a, 1-oxacephem 73a, penicillin 1, and carbapenem 74a, respectively, the values being in good agreement with their activities in a qualitative sense.
We suspected that the way yielding a large h value comparable to that of carbapenem was to connect the C2 and C7 with one or two carbons at the 0-side to form 75, for example. This idea was not unreasonable, since there were reports (ref. 16 ) that introduction of a methyl group a t the 2p position in 1-oxacephem and at the 10 osition in carbapenem did not reduce, the original activity. Moreover, lack of two methyl groups at 8 2 in penicillin was reported to lower the activity. On the contrary, dialkylation at c 6 in penem was reported to result in a complete loss of the activity suggesting evidence CHART 14 against our idea. However, we were optimistic at this point, because, in a rigid ring system like 75, steric hindrance towards the P-lactam carbonyl might be reduced as in case of camphor whose carbonyl reactivity retained in spite of disubstitution a t the neighbouring bridge-head. Before carrying out the synthesis, the stereostructure of 75 was compared with the stereogra hs of ID-methylcarbapenem 74b and l-oxaceptem 73a with the aid of computer graphics. The three stereographs were determined by Dr. Ezumi using the AM-I method and is shown in Fig. 1 . The bridged 1-oxacephem 75, IDmethylcarbapenem 74b, and 1-oxacephem are drawn by red, yellow, and blue lines respectively with the common axis of the nitrogen and c6. It was clear that the molecules of the bridged 1-oxacephem and ID-methyl carbapenem were roughly superimposed, whereas the 1-oxacephem molecule was largely apart.
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( 1 ) Bu4NFlHOAc 
CHART 15
Encouraged by this result we undertook the synthesis of the bridged 1-oxacephem 75 of the 4,6,6 tricyclic ring system. Reaction of 4P-acetoxyazetidinone 57 with racemic 5-chloro-3-hydroxy-lpentene gave a 1:l mixture of 77 which was separated into two etherealisomers in 46 and 45% yield respectively. In order to effect intramolecular cyclization, compound 77 was converted into 79 via 78 as shown in Chart 15. This is because that cyclization of 0,N-bissilyl compound failed giving mainly an olefinic compound and it was expected that the carbanion-alkoxide dianion from the hydroxyethyl compound would be less vulnerable to the elimination of the hydroxy functionality. Indeed, the hydroxyethyl compound 79 derived from the more polar isomer of 77 was cyclized smoothly by treatment with LDA at -60°C to obtain the bicyclic compound 80. The configuration of this intermediate was confirmed by X-ray crystallography. This was converted into a Woodward phosphorane 82 which was then cyclized to the tricyclic compound 83 in 90% yield. Astonishingly, this cyclization required an unusually high temperature and a long reaction time, suggesting that a highly strained intermediate is induced in the transition state. This was either desilylated and subsequently ester deprotected to obtain 84 or transformed via 85 into 86, the desired target compound. The structure of this compound 86 was confirmed by X-ray analysis of the tricyclic ketone p-methylbenzyl ester derived from desilylation and subsequent Swern oxidation of 83. The three dimensional structure of the keto ester is iven in Fig. 2 In conclusion, we believe, we have made significant contributions to the chemistry and the biology of 0-lactam antibiotics by exploring the 1-oxanuclear analogs of naturally occurring P-lactam antibiotics, which comprise a new class of the antibiotics and are available only artificially. In this sense, synthetic chemistry was recognized as a very important tool both in precision and usefulness and has been developed extensively. As a result we were successful not only in elucidating the biological properties of 1-oxacephems, but also in producing two useful injectable antibiotics of this type which are currently applied for treating infectious diseases.
X-Ray crystalography
In closing my lecture, I would like to mention that the work has been done cooperatively by a number of scientists in Shionogi Research Laboratories. The most recent work concerning with the syntheses of 1-oxa nuclear analogs lacking the acylamido side chain was performed with the earnest and skilled cooperation of Dr 
